Wednesday, March 30, 2016
The degree to which an individual deviates in intelligence from their family is a more accurate predictor of schizophrenia development than the individual’s intelligence alone, according to a new study conducted by researchers at Virginia Commonwealth University and Lund University in Sweden.
The study confronts the conventional wisdom that low intelligence alone is a sufficient risk factor for schizophrenia development, going further to say that the risk for schizophrenia development is more accurately indexed by the degree to which an individual diverges from their family’s average intelligence level.
It is all in the deviation from the family expectation.
“Merely not doing well in school is not predictive,” said first author Kenneth S. Kendler, M.D., professor of psychiatry and human and molecular genetics in the Department of Psychiatry, VCU School of Medicine. “It is all in the deviation from the family expectation. If you have poor cognitive performance, but you come from a family where that is normal, then you do not have an increased risk of illness.”
Relatedly, someone could be a high academic achiever compared to the average student, but if they came from a family of intellectually superior people and were falling short of their family’s average intelligence then they would have a substantially increased risk for developing schizophrenia.
More than 1 million individuals born in Sweden between 1972 and 1990 were included in the study that predicted schizophrenia development based on school achievement and IQ as well as the deviation of that performance from the individual’s familial cognitive aptitude. Familial cognitive aptitude was calculated from the school achievement, IQ and educational attainment of biological relatives.
“In a family that is intellectually average, if you are really smart then your risk of schizophrenia will be about half of that of the rest of the population,” Kendler said. “A person of average intelligence who comes from a brilliant family has almost a three-fold risk of developing schizophrenia.”
While the basic etiological research does not directly benefit individuals who suffer from schizophrenia in the immediate future, it does help to clarify how cognitive performance affects schizophrenia development risk, and thus paves the way for treatment possibilities down the road.
The study, which is titled “Observed Cognitive Performance and Deviation from Familial Cognitive Aptitude at Ages 16 and 18-20, and Risk for Schizophrenia and Bipolar Illness in a Swedish National Sample,” was published in the Journal of the American Medical Association Psychiatry journal on March 30. It will be published again in an upcoming print issue of the journal.
Kendler, director of the Virginia Institute for Psychiatric and Behavioral Genetics at VCU, collaborated on the study with VCU School of Medicine associate professor Briana Mezuk, Ph.D., as well as with Lund University researchers Henrik Ohlsson, Ph.D.; Jan Sundquist, M.D., Ph.D.; and Kristina Sundquist, M.D., Ph.D. Sundquist and Sundquist also have affiliations with the Stanford Prevention Research Center at the Stanford University School of Medicine.
About VCU and VCU Health
Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 217 degree and certificate programs in the arts, sciences and humanities. Thirty-eight of the programs are unique in Virginia, many of them crossing the disciplines of VCU’s 11 schools and three colleges. The VCU Health brand represents the VCU health sciences academic programs, the VCU Massey Cancer Center and the VCU Health System, which comprises VCU Medical Center (the only academic medical center in the region), Community Memorial Hospital, Children’s Hospital of Richmond at VCU, MCV Physicians and Virginia Premier Health Plan. For more, please visit www.vcu.edu and vcuhealth.org.